Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Filings indexed 423 across all filing types
Latest filing 2024-12-06 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings
2024-12-06 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates and the consequent stop transfer of shares until duplicate certificates are issued. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share transfer restrictions in case of lost certificates. The content is a notification about share certificate status and does not contain financial data, management discussion, or report publication. It is not an annual or quarterly report, earnings release, or any form of audit or governance report. It is also not a voting result, capital change, or director dealing. The document is a regulatory compliance announcement related to share transfer and certificate loss, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-12-06 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges and compliance departments regarding the loss of share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the handling of lost share certificates and issuance of duplicates. The content includes details such as folio number, certificate numbers, distinctive numbers, number of shares, and the reason for stop transfer (loss by holder). This is a notification about a specific event related to share certificates, not a financial report, management change, or earnings release. It is a regulatory compliance announcement related to share transfer restrictions due to lost certificates. The document length is short (2328 characters) and it is an intimation to exchanges, fitting the category of Regulatory Filings (RNS) as it does not fit other specific categories like Director's Dealing or Share Issue/Capital Change. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-12-06 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification sought on the increase in trading volume of the company's shares. It states that the company has no information or announcement that would affect the share price or volume and references compliance with SEBI regulations. The document is a regulatory communication responding to an inquiry, not a financial report, earnings release, or any other specific filing type. It is short and serves as a formal regulatory disclosure or clarification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents.
2024-12-04 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates and the consequent stop transfer of shares until duplicate certificates are issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and transfer restrictions. The document is short (2307 characters) and serves as an intimation or notification rather than a detailed report or financial statement. It does not contain financial data, audit information, management changes, or earnings details. It is a regulatory compliance notification related to share transfer restrictions due to lost share certificates. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-03 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the loss of share certificates and the consequent stop transfer of those shares until duplicate certificates are issued. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and transfer restrictions. The content is a compliance/intimation notice rather than a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. It is a regulatory announcement related to share transfer compliance and not a report or detailed filing. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.